Skip to main content
Adaptimmune Therapeutics plc (ADAP)
NASDAQ: ADAP · IEX Real-Time Price · USD
1.140
+0.130 (12.87%)
At close: Apr 23, 2024, 4:00 PM
1.150
+0.010 (0.88%)
After-hours: Apr 23, 2024, 7:59 PM EDT

Adaptimmune Therapeutics Market Cap

Adaptimmune Therapeutics has a market cap or net worth of $250.43 million as of April 23, 2024. Its market cap has increased by 11.35% in one year.

Market Cap
250.43M
Enterprise Value
125.70M
1-Year Change
11.35%
Ranking
#3530
Category
Micro-Cap
Stock Price
$1.14

Market Cap Chart

Since March 31, 2016, Adaptimmune Therapeutics's market cap has decreased from $575.60M to $250.43M, a decrease of -56.49%. That is a compound annual growth rate of -9.80%.

History

DateMarket Cap% Change
Apr 22, 2024249.30M3.36%
Apr 19, 2024241.20M8.80%
Apr 18, 2024221.70M-9.03%
Apr 17, 2024243.70M-4.17%
Apr 16, 2024254.30M-1.89%
Apr 15, 2024259.20M-9.50%
Apr 12, 2024286.40M-10.08%
Apr 11, 2024318.50M1.59%
Apr 10, 2024313.50M-7.30%
Apr 9, 2024338.20M0.74%
Apr 8, 2024335.70M-0.74%
Apr 5, 2024338.20M1.47%
Apr 4, 2024333.30M-2.17%
Apr 3, 2024340.70M-1.42%
Apr 2, 2024345.60M-4.77%
Apr 1, 2024362.90M-6.97%
Mar 28, 2024390.10M-
Mar 27, 2024390.10M3.97%
Mar 26, 2024375.20M5.54%
Mar 25, 2024355.50M-
Mar 22, 2024355.50M7.47%
Mar 21, 2024330.80M0.76%
Mar 20, 2024328.30M-5.69%
Mar 19, 2024348.10M-4.08%
Mar 18, 2024362.90M-0.68%
View and export this data all the way back to 2016. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
AngioDynamics 250.74M
Verastem 248.91M
Utah Medical Products 246.13M
XBiotech 244.71M
Xeris Biopharma Holdings 244.39M
Pyxis Oncology 241.83M
Puma Biotechnology 241.52M
Telomir Pharmaceuticals 236.43M
Market Cap Rankings